SCHEMBL6091552

SCHEMBL6091552

CCOC(=O)C(C)(C)Oc1ccc(CO)cc1-c1cccs1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
KEAP1 Q14145 1/20 0.41
KDM4E B2RXH2 4/20 0.41
HPGD P15428 3/20 0.41
NPSR1 Q6W5P4 2/20 0.41
LMNA P02545 1/20 0.41
HTT P42858 1/20 0.41
FBP1 P09467 6/20 0.40
PPARA Q07869 3/20 0.39
PPARG P37231 2/20 0.39
ABCB11 O95342 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
TSHR P16473 1/20 0.39
HTR2A P28223 1/20 0.39
PMP22 Q01453 1/20 0.39
TP53 P04637 1/20 0.39
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6092109 0.90 ALDH1A1 (0.41) ALDH1A1GAAMAPTKEAP1KDM4E
SCHEMBL6092795 0.83 FBP1 (0.46) ALDH1A1GAAMAPTKEAP1KDM4E
SCHEMBL6091637 0.83 TNFRSF1A (0.41) ALDH1A1GAAMAPTKEAP1KDM4E
SCHEMBL6094551 0.81 HDAC1 (0.47) ALDH1A1KDM4EFBP1PPARAABCB11
SCHEMBL4681712 0.78 FBP1 (0.56) FBP1PPARAPPARGABCB11CYP1A2
SCHEMBL6040611 0.77 TNFRSF1A (0.52) ALDH1A1GAAMAPTKEAP1KDM4E
SCHEMBL6040642 0.77 TNFRSF1A (0.48) ALDH1A1GAAMAPTKEAP1KDM4E
SCHEMBL4678053 0.76 FBP1 (0.58) MAPTHPGDHTTFBP1PPARA
SCHEMBL6092792 0.76 DRD2 (0.35) ALDH1A1GAAMAPTHPGDNPSR1
SCHEMBL6094343 0.76 ERN1 (0.50) FBP1HDAC3HDAC1HDAC2TNFRSF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060063828-A1 1,2-Bis-(substituted-phenyl)-2-propen-1-ones and pharmaceutical compositions thereof ATHEROGENICS, INC. 2006-03-23 US disclosed
WO-2006004903-A2 1,2-BIS-(SUBSTITUTED-PHENYL)-2-PROPEN-1-ONES AND PHARMACEUTICAL COMPOSITIONS THEREOF ATHEROGENICS, INC. (US) 2006-01-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060063828-A1 1,2-Bis-(substituted-phenyl)-2-propen-1-ones and pharmaceutical compositions thereof ABCB11, CEL, CYP46A1 ALDH1A1 159/4885GAA 504/4885MAPT 1784/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.